Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.9 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |